Asian Penny Stocks With Market Caps Under US$2B To Consider

Simply Wall St

Sun, March 29, 2026 at 7:02 PM EDT 4 min read

Amidst the backdrop of geopolitical tensions and fluctuating energy prices, Asian markets are navigating a complex landscape that has investors on edge. While large-cap stocks often dominate headlines, penny stocks—despite their old-fashioned name—remain an intriguing option for those seeking to explore smaller or newer companies with potential upside. By focusing on firms with strong financials and growth prospects, investors can uncover hidden value in these lesser-known equities.

Click here to see the full list of 978 stocks from our Asian Penny Stocks screener.

We’ll examine a selection from our screener results.

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Jinhai Medical Technology Limited is an investment holding company offering minimally invasive surgery solutions, medical products, and related services in China and Singapore, with a market cap of HK$11.85 billion.

Operations: Revenue segments for the company have not been reported.

Market Cap: HK$11.85B

Jinhai Medical Technology Limited, with a market cap of HK$11.85 billion, is currently unprofitable but has demonstrated some financial stability by maintaining more cash than its total debt and covering both short and long-term liabilities with its short-term assets. Despite a decline in revenue from SGD 50.24 million to SGD 46.28 million for the year ended December 31, 2025, the company reduced its net loss slightly to SGD 17.08 million. Its board and management team are experienced, with recent leadership changes including the appointment of Mr. Li Bin as co-chairman to potentially bolster strategic direction.

• Dive into the specifics of Jinhai Medical Technology here with our thorough balance sheet health report.

• Gain insights into Jinhai Medical Technology’s past trends and performance with our report on the company’s historical track record.

Simply Wall St Financial Health Rating: ★★★★★★